GelMEDIX

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.

PMV mark · valuation
$21.0M
Oct 2026
Priced at
its seed round
Feb 2026
Total raised
$30.7M
Last round
Seed Round
Oct 2025
What is GelMEDIX worth?
$21.0MPrivateMarketView mark · Oct 2026

Valued at $21.0M at its seed round, Feb 2026. Nothing has traded since.

Free account
More of GelMEDIX with a free account
  • ·Watch GelMEDIX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

GelMEDIX funding history

4 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$747K▮
Jan 2025Seed Round$1.0M▮
Mar 2024Debt$1.9M▮
Jun 2020Early Stage VC$6.4M▮
Unlock post-money valuations

Membership and data by Private Market View

GelMEDIX valuation

GelMEDIX was valued at $21 million at its seed round in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has GelMEDIX raised?

GelMEDIX has raised $30.7 million in total; 4 of its rounds are on record, from 2020 on. The largest on record was a $747,000 seed round in Oct 2025.

GelMEDIX has filed 6 Form Ds with the SEC since 2020, most recently in Apr 2026 ($747,000 sold to 5 investors).

How GelMEDIX's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For GelMEDIX, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about GelMEDIX

What is GelMEDIX worth?
GelMEDIX is valued at $21.0M as of Oct 2026. Valued at $21.0M at its seed round, Feb 2026. Nothing has traded since.
How much has GelMEDIX raised?
GelMEDIX has raised $30.7M in total funding across 4 recorded rounds.
When did GelMEDIX last raise?
GelMEDIX last raised in Oct 2025 (Seed Round), raising $747K.